berry_cristan @berry_cristan
The SARM1 targeting therapeutics market is projected to grow at a CAGR of 102.1%, during the period 2033-2040, claims Roots Analysis

SARM1 inhibitors, having demonstrated the ability to prevent axonal degeneration, are being evaluated for the treatment of a number of neurodegenerative disorders. Once approved, these therapies are likely to capture a significant market share

For additional details, please visit https://www.rootsanalysis.... or email
11:58 AM - Jan 23, 2023
Only people mentioned by berry_cristan in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from berry_cristan , click on at the bottom under it